 | ACADIA Pharmaceuticals Inc. | |||
| NMS : ACAD || Location: United States | ||||
$17.19+0.11 (+0.64%) |
1.03 M | 16.97 - 17.25 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 11.197 M |
| March 15, 2024 | 10.630 M |
| Feb. 29, 2024 | 10.806 M |
| Feb. 15, 2024 | 9.419 M |
| Jan. 31, 2024 | 7.676 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.31 | 0.28 | -9.65% |
| 09/30/2023 | -0.43 | -0.40 | 7.96% |
| 06/30/2023 | -0.08 | 0.01 | 111.86% |
| 03/31/2023 | -0.22 | -0.27 | -23.29% |
| 12/31/2022 | -0.25 | -0.26 | -4.92% |
ACAD Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 164.772M | Shares Float | 109.866M |
| Short Float | 11.197M | Market Cap | 2814.31M |
| Institution ownership | 99.57% | Insider ownership | 0.492% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.37 | Forward EPS | 1.29 |